Search results for “PTK Inhibitors” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 5,808 patents, we discovered top 372 key players by total patent application. Vertex Pharmaceuticals, Inc., IRM LLC, Novartis AG are dominant in this area. They take 28.25% of the total patent filing.
Vertex Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 892
IRM LLC
CITY OF HAMILTON, Bermuda
Patent: 449
Novartis AG
Basel-Stadt, Switzerland
Patent: 300
Array BioPharma, Inc.
Colorado, United States
Patent: 265
Genentech, Inc.
California, United States
Patent: 201
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 141
Sugen, Inc.
New York, United States
Patent: 140
Pfizer Inc.
New York, United States
Patent: 126
Xigen Inflammation Ltd
United States
Patent: 120
Schering Corp.
New Jersey, United States
Patent: 95
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 96 patents, we discovered top 11 start-ups by total patent application. HepaRegeniX GmbH, Wellmarker Bio Co., Ltd., Sumitomo Dainippon Pharma Oncology, Inc. are active in this area.
STARTUP
HepaRegeniX GmbH
Baden-Württemberg, Germany
Patent: 30
STARTUP
Wellmarker Bio Co., Ltd.
South Korea
Patent: 15
STARTUP
Sumitomo Dainippon Pharma Oncology, Inc.
United States
Patent: 11
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 11
STARTUP
GEn1E Lifesciences, Inc.
California, United States
Patent: 9
STARTUP
Shanghai KeChow Pharmaceuticals Co., Ltd.
Shanghai Shi, China
Patent: 9
STARTUP
Chengdu Hyperway Pharmaceuticals Co., Ltd.
Sichuan Sheng, China
Patent: 4
STARTUP
Dermavant Sciences GmbH
Basel-Stadt, Switzerland
Patent: 2
STARTUP
iOmx Therapeutics AG
Bayern, Germany
Patent: 2
STARTUP
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 702 patents applied in the last 5 years. We discover 157 most active companies in this area. The fast-growing HepaRegeniX GmbH, Shenzhen Chipscreen Biosciences Co., Ltd., Nanocopoeia, Inc. take 12.82% of patent filing during this period.
STARTUP
HepaRegeniX GmbH
Baden-Württemberg, Germany
Patent: 30
Shenzhen Chipscreen Biosciences Co., Ltd.
Guangdong Sheng, China
Patent: 30
Nanocopoeia, Inc.
Minnesota, United States
Patent: 30
Beijing Tide Pharmaceutical Co., Ltd.
Beijing Shi, China
Patent: 26
Oncostellae SL
Spain
Patent: 23
Shengke Pharmaceutical (Jiangsu) Co., Ltd.
China
Patent: 20
Korea Institute of Science & Technology
South Korea
Patent: 19
BCI Pharma SAS
France
Patent: 17
LG Chem Ltd.
South Korea
Patent: 16
Chongqing Fuchuang Pharmaceuticals Research Co Ltd
Chongqing Shi, China
Patent: 16
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 702 patents in last 5 years, we discover 89 new entrants. Nanocopoeia, Inc., HepaRegeniX GmbH, Oncostellae SL are the most active new entrants in this area.
Nanocopoeia, Inc.
Minnesota, United States
Patent: 30
STARTUP
HepaRegeniX GmbH
Baden-Württemberg, Germany
Patent: 30
Oncostellae SL
Spain
Patent: 23
Shengke Pharmaceutical (Jiangsu) Co., Ltd.
China
Patent: 20
LG Chem Ltd.
South Korea
Patent: 16
Kymera Therapeutics, Inc.
Massachusetts, United States
Patent: 13
Chengdu Chipscreen Pharmaceutical Ltd.
Sichuan Sheng, China
Patent: 13
Dizal Pharmaceutical Co., Ltd
Jiangsu Sheng, China
Patent: 11
University of Freiburg
Baden-Württemberg, Germany
Patent: 10
Guangzhou Runer Ophthalmic Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 10
Research Institutions
Order by:
Innovation Intensity
With the analysis among 469 patents, we discovered top 64 universities and scientific research institutions by total patent application. The Scripps Research Institute, Korea Institute of Science & Technology, Shanghai Institute of Materia Medica Chinese Academy of Sciences are dominant in this area. They take 36.46% of the total patent filing.
The Scripps Research Institute
California, United States
Patent: 93
Korea Institute of Science & Technology
South Korea
Patent: 55
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 21
Institute Of Cancer Research
United Kingdom
Patent: 20
Regents of the University of Colorado
Colorado, United States
Patent: 12
Jinan University
Guangdong Sheng, China
Patent: 10
University of Freiburg
Baden-Württemberg, Germany
Patent: 10
Shenyang Pharmaceutical University
Liaoning Sheng, China
Patent: 10
Princeton University
New Jersey, United States
Patent: 8
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 7
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: